Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 25Kidney Neoplasms 6Neoplasms 5Neoplasm Metastasis 4Clear-cell metastatic renal cell carcinoma 4Uterine Cervical Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Diseases 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

tremelimumab 4Ipilimumab 4lenvatinib 3durvalumab 3Nivolumab 3pembrolizumab 2balstilimab 2Pemetrexed 2Carboplatin 2Bevacizumab 2spartalizumab 1relatlimab 1poly ICLC 1osimertinib 1cemiplimab 1Vemurafenib 1Vascular Endothelial Growth Factor A 1Standard of Care 1Platinum 1Peptides 1Paclitaxel 1Opdualag 1Docetaxel 1Capecitabine 1Blood Specimen Collection 1Axitinib 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Insulin-Dependent, 12 × Axitinib × 1 year × Clear all
NCT04522323 2025-07-25

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

MedImmune LLC

Phase 1 Active not recruiting
67 enrolled
Genitourinary

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡